Chemoid Cg03-Eoc- Standard Chemotherapy Versus Cancer Stem Cell Assay Directed Chemotherapy In Recurrent Platinum Resistant Ovarian Cancer
Posted Date: Dec 30, 2019
- Investigator: Thomas Herzog
- Specialties: Cancer, Oncology, Ovarian Cancer
- Type of Study: Drug
The purpose of this study is to study Overall Response rate, progression free survival, and duration of response in standard chemotherapy vs Stem cell directed chemotherapy in recurrent ovarian cancer.
Criteria:
To Be Eligible: Diagnosed With Recurrent Epithelial Ovarian, Peritoneal, Or Fallopian Tube Carcinoma, >18 Years Of Age, Life Expectency >6 Months, No Severe Medical Conditions Or Infections That Would Interfere With Study
Keywords:
Ovarian Cancer, Peritoneal Cancer, Oncology
For More Information:
Uc Cancer Center
513-584-7698
cancer@uchealth.com